Drug Profile
M 23
Alternative Names: rscu-PA-40kDa/HirLatest Information Update: 31 May 2001
Price :
$50
*
At a glance
- Originator Grunenthal
- Class Thrombolytics
- Mechanism of Action Plasminogen activator stimulants; Platelet aggregation inhibitors; Thrombin inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Thrombosis